Projects per year
Projects 2004 2020
Active
Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer
Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.
10/1/08 → 8/31/20
Project: Research project
Ovarian Neoplasms
alvocidib
Registries
Research
Translational Medical Research
Finished
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
Perez, E. A., Clynes, R. & Knutson, K. L.
1/1/11 → 12/31/16
Project: Research project
Immunity
Drug Therapy
Breast Neoplasms
Antibody Formation
Trastuzumab
Analysis of serum folate receptor and antibody level for ovarian cancer detection
9/19/06 → 8/31/09
Project: Research project
Folate Receptor 1
Folic Acid
Ovarian Neoplasms
Antibodies
Serum
Immunity
Histocompatibility Antigens Class I
Breast Neoplasms
Peptides
Neoplasm Antigens
Helper-Inducer T-Lymphocytes
Cytotoxic T-Lymphocytes
Neoplasms
T-Lymphocytes
Th2 Cells
Neoplasm Antigens
Epitopes
Antigens
Immunization
Subunit Vaccines